ABOUT
Wanxiang Healthcare Investments, founded in 2016, is a corporate venture arm of Wanxiang America investing in healthcare technology, with an emphasis on digital health, from late seed to Series C. Its portfolio includes Augmedix.
PORTFOLIO · 2 COMPANIES
ROUNDS · 1
Wanxiang Healthcare Investments took part in 1 round on listed companies. 1 has a public amount, totalling US$19Mn in round size (the investor's own cheque is not disclosed).
DATECOMPANYROUNDAMOUNTROLE
Amounts appear only where a public source exists. Round size, not the investor's cheque.
See something wrong? Suggest a correction.
